Under EMIR reporting mandates from 11th August 2014, EU Financial Counterparties (FC) and Non-Financial Counterparties above the clearing threshold (NFC+) must report daily collateral and valuation data relating to their open trades and positions to an EMIR Trade Repository.
CME Clearing US has extended its complementary delegated reporting services to cover the expanded scope. Please note that for cleared markets, only the CCP valuation mark may be used to comply with EMIR reporting. CME Clearing US’ offering is a direct from the source solution.
Delegated Reporting Customer Impact (US Markets only):
· Clients participating in CME Clearing US’s Delegated Reporting Service will automatically include the submission of collateral and valuation data at no additional cost from 11th August into CME ETR
· New participants to the service may begin the registration process with completing the form at http://www.cmegroup.com/trading/files/cme-robo-service-registration-form-for-us-markets.zip. Upon set up completion, CME will report trades and positions in addition to the new collateral and valuation requirements.
Delegated Reporting FCM Impact:
· No action is required by FCM or client if previously enrolled for delegated reporting services on trades and positions
** Please note that the information above pertains only to CME cleared markets in the US. Clients and Clearing members of CME cleared markets in the EU through CME Clearing Europe will receive a separate advisory shortly. **
Direct Reporting
Clients with an EMIR obligation may self-report along with FCMs who may directly self-report house business on any market, CME or non-CME, in all asset classes to our ESMA registered Trade Repository.
For more information, please visit www.cmegroup.com/etr
To find out more about CME Group's delegated reporting service for both FCMs and Clients, or for any other EMIR reporting questions or concerns, please contact:
CME Global Repository – Client Services | repositorysupport@cmegroup.com|
Chicago +1 (312) 580 5352 | London +44 (0) 203 379 3180 | Singapore +65 6593 5592
For the printer friendly version of this advisory, please click here.